Literature DB >> 25977389

Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study.

Maria Caterina Pace1, Maria Beatrice Passavanti1, Caterina Aurilio1, Pasquale Sansone1, Rossella Aurilio1, Salvatore DE Maria2, Stefania Lama3, Alessandro Federico4, Gianpietro Ravagnan2, Michele Caraglia5, Paola Stiuso5.   

Abstract

AIM: Polydatin, a hydroxystilbene derived from the rhizome of Polygonum cuspidatum, elicits hepatoprotective and neuroprotective effects through its anti-oxidant properties. The present study aimed to determine the effects of oral administration of polydatin in alcoholic patients in order to improve liver biochemical parameters, serum oxidative stress and mental state. We enrolled 20 chronic alcoholic patients hospitalized for rehabilitative therapy. The patients were divided into two groups receiving the following treatment regimes for two weeks: administration of an anti-oxidant nutritional supplement containing glutathione and vitamin C (group 1), or glutathione, vitamin C and polydatin (group 2).
RESULTS: The results of the present study show that elevated plasma aspartate aminotransferase and alanine aminotransferase levels in patients after two weeks of alcohol withdrawal were significantly reduced by polydatin (group 2), when compared to group 1. Polydatin also significantly reduced lipid peroxidation levels. Finally, our preliminary data resulting from the analysis of the Mini-Mental Status suggest that polydatin improves cognitive performance.
CONCLUSION: Daily dietary administration of polydatin should be considered for prevention and treatment of liver disease and cognitive impairment in alcoholic patients.
Copyright © 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Polydatin; alcohol; lipid peroxidation; liver injury; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25977389

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

1.  Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway.

Authors:  Yi-Li Jin; Li-Min Xin; Chang-Chun Zhou; Yu Ren
Journal:  Onco Targets Ther       Date:  2018-11-16       Impact factor: 4.147

2.  Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study.

Authors:  Maria Pia Fuggetta; Maria Rita Migliorino; Serena Ricciardi; Giorgia Osman; Daniela Iacono; Alvaro Leone; Alessandra Lombardi; Giampietro Ravagnan; Stefania Greco; Daniele Remotti; Maria Concetta Pucci Romano
Journal:  Scientifica (Cairo)       Date:  2019-01-31

3.  Protective Effects of Polydatin Against Dementia-Related Disorders.

Authors:  Kim San Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 4.  Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.

Authors:  Ahmad Karami; Sajad Fakhri; Leila Kooshki; Haroon Khan
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

5.  Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation.

Authors:  Zhen Li; Lu Zhou; Yiwei Du; Huirong Li; Lan Feng; Xiangnan Li; Xiao Han; Hongbao Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-16       Impact factor: 7.310

6.  New intriguing possibility for prevention of coronavirus pneumonitis: Natural purified polyphenols.

Authors:  Lorenzo Lo Muzio; Maria Eleonora Bizzoca; Giampietro Ravagnan
Journal:  Oral Dis       Date:  2020-07-14       Impact factor: 4.068

7.  Polydatin, Natural Precursor of Resveratrol, Promotes Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Adriana Di Benedetto; Francesca Posa; Salvatore De Maria; Giampietro Ravagnan; Andrea Ballini; Chiara Porro; Teresa Trotta; Maria Grano; Lorenzo Lo Muzio; Giorgio Mori
Journal:  Int J Med Sci       Date:  2018-06-13       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.